Related Experiment Videos
[Gardner syndrome: clinical and epidemiologic up to date]
T Losacco1, C Punzo, L Santacroce
1D.O.C., Cattedra di Chirurgia Generale, Università degli Studi di Bari, Italia.
La Clinica Terapeutica
|February 9, 2006
Summary
Gardner syndrome, a condition with familial colonic polyposis and osteomas, significantly increases colon cancer risk. Early detection protocols are crucial for managing this severe genetic disorder.
Area of Science:
- Genetics
- Oncology
- Gastroenterology
Background:
- Gardner syndrome is characterized by familial colonic polyposis, osteomas, soft tissue cysts, and fibrous lesions.
- It involves early onset of osteomas and dental inclusions in maxillary bones.
- The condition is life-threatening due to poor quality of life and 100% progression of colonic polyps to colon cancer.
Purpose of the Study:
- To review the pathophysiology and clinical aspects of Gardner syndrome.
- To report institutional data on epidemiology and clinical presentation.
- To develop a clinical protocol for early detection.
Main Methods:
- Literature review of pathophysiologic and clinical aspects.
- Analysis of institutional clinical data on epidemiology and presentation.
- Elaboration of a clinical protocol for early detection.
Main Results:
- Gardner syndrome presents with a distinct set of symptoms including colonic polyposis and osteomas.
- High-risk progression to colon cancer necessitates proactive management.
- Institutional data provides insights into the condition's epidemiology and clinical manifestations.
Conclusions:
- Gardner syndrome is a severe condition requiring comprehensive understanding and management.
- Early detection and intervention are critical for improving patient outcomes.
- A standardized clinical protocol can aid in the early identification of Gardner syndrome.
Related Concept Videos
Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Prevalence and Incidence
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...